Initial public offerings worth USD 20 billion per annum are the "new normal" for India and will become an annualised run rate over the next few years, one of the biggest investment bankers said on Tuesday. The market, which has seen a slew of initial share sales this fiscal, has already witnessed USD 21 billion of issuances in 2025, the same as last year, and we should close the year with over USD 23 billion, given the fact that some large issues like the Rs 10,000 offering from ICICI Prudential AMC are in process, said JP Morgan. "Yearly issuance of USD 20 billion is the new normal for India. It is the new watermark and will become an annualized run rate from here on," its head of equity capital markets, Abhinav Bharti, told reporters here. Bharti said nearly a fifth of the demand is getting driven by consumer technology and new age businesses, and the same will go above 30 per cent as well over the next five years. He said at least 20 startups, which command valuations in hundred
Brokerages say Biocon's move to fully acquire Biocon Biologics simplifies structure and unlocks value, but near-term stock pressure likely due to dilution and fundraising
Nephrocare Health IPO comprises a fresh issue of 7.7 million, amounting to ₹353.4 crore and an offer for sale (OFS) of 11.3 million equity shares amounting to ₹517.64 crore
The three-day subscription window to bid for the Park Medi World IPO will close on Friday, December 12, 2025
Ajmera Realty shares rose 4 per cent after it launched a premium and mid-segment residential project and recorded an 81 per cent sell-out within hours
Ahead of its listing, the unlisted shares of Aequs were trading at around ₹152 per share in the grey market, indicating a premium of ₹28 or 22.6 per cent
Swiggy shares rose 3 per cent after its shareholders approved raising up to ₹10,000 crore via qualified institutional placement
On Tuesday, DGCA directed IndiGo to reduce winter schedule by 5 per cent across sectors, especially on high-frequency flights. Meanwhile, IndiGo share price is down 18 per cent in December 2025
Kotak Institutional Equities, last week, flagged in a report inconsistencies in Kaynes Tech's related party transactions, an ambiguous accounting treatment of goodwill, among other issues
In the broader market, the Nifty Midcap 100 and Nifty Smallcap 100 indices fell 1.5 per cent, each. The small-cap index has fallen 3.3 per cent since Monday
After significant outflows around $8 billion overall and $17 billion from equities, FII holdings are at multi-year lows, said Ankur Jhaveri of JM Financial Institutional Securities
Ambit expects TMCV's revenue and Ebitda to grow at a CAGR of 6 per cent and 7 per cent over FY25-28, respectively, on the back of high-margin and non-core revenues
As per reports, US President, Donald Trump is expected to levy tariffs on rice imported from India
MOFSL has named Max Financial Services Ltd (MFSL), the parent of Max Life Insurance, as its preferred pick in the sector
Motilal Oswal remains positive on the telecom sector and maintains 'Buy' ratings on Bharti Airtel and Reliance Jio via Reliance Industries
Overall subscription for Meesho IPO was strong at 79.03 times, with total bids at 21.96 billion shares against the 277.93 million shares on offer
The optimism stems from the company's plan to increase its stake in Biocon Biologics (BBL), the expected consolidation of the Biologics arm, and improving fundamentals
According to Shrikant Chouhan of Kotak Securities, Prestige remains well placed to benefit from sectoral tailwinds, and ITC continues to position itself as a future-ready Indian conglomerate
According to Motilal Oswal, defence electronics continues to see long-term demand for radars, avionics, communication systems and electronic warfare solutions
The BSE Sensex tumbled 803 points in the intraday to hit a low of 84,909, and the NSE Nifty50 also slipped below the 26,000 mark in the intraday to hit a low of 25,902.95